A stagewise response to mitochondrial dysfunction in mitochondrial DNA maintenance disorders.
Biochim Biophys Acta Mol Basis Dis
2024
1870
5
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
J Neurol
2024
271
6
3702-3707
Addressing uncertainties in correlative imaging of exogenous particles with the tissue microanatomy with synchronous imaging strategies.
Metallomics
2023
15
6
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.
J Neurol
2023
270
7
3341-3368
Vaccination frequency in people newly diagnosed with multiple sclerosis.
Mult Scler
2023
29
14
1831-1840
Regulation of the programmed cell death protein 1/programmed cell death ligand 1 axis in relapsing-remitting multiple sclerosis.
Brain Commun
2023
5
4
Performance of serum neurofilament light chain in a wide spectrum of clinical courses of amyotrophic lateral sclerosis-a cross-sectional multicenter study.
Eur J Neurol
2023
30
6
1600-1610
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
J Neurol
2024
271
1
141-176
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases COPANMO(G)-Study
Neurol Neuroimmunol Neuroinflamm
2023
10
2